Immunocellular Therapeutics, Ltd. (IMUC) Tops Q4 EPS by 9c
Immunocellular Therapeutics, Ltd. (NYSE: IMUC) reported Q4 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
